Study Description
The purpose of this study is to evaluate the effect of sacubitril/valsartan 200 mg BID compared with enalapril 10 mg BID, in addition to conventional heart failure (HF) treatment, in improving a hierarchical composite of cardiovascular (CV) events (i.e. CV death or the occurrence of first HF hospitalization) and causing a greater reduction in n terminal prohormone of brain natriuretic peptide (NT-proBNP, at Week 12 from Baseline) in participants with HF with reduced ejection fraction (HFrEF) caused by CCC.
Interventions
Enalapril
Sacubitril/valsartan
Eligibility Criteria
Key Inclusion Criteria:
Male or female ≥ 18 years of age
Diagnosis of NYHA Class II-IV HFrEF established by:
LVEF ≤ 40% within 12 months prior to Visit 1 made by any local measurement using echocardiography, multiple gated acquisition scan (MUGA), computerized tomography (CT) scanning, magnetic resonance imaging (MRI), or ventricular angiography, provided no subsequent measurement above 40% AND
NT-proBNP ≥ 600 pg/mL (or BNP ≥ 150 pg/mL) at Visit 1 OR
NT-proBNP ≥ 400 pg/mL (or BNP ≥ 100 pg/mL) at Visit 1 and a hospitalization for HF within the last 12 months
Chagas' disease diagnosis confirmed by at least two different serological tests for anti-Trypanosoma cruzi based on different principles or with different antigenic preparations, such as: enzyme-linked immunosorbent assay [ELISA], indirect immunofluorescence [IFI], indirect hemagglutination [IHA], western blot (WB), chemiluminescent immunoassay (CLIA). If documented history is not available, the tests may be performed during the screening
Key Exclusion Criteria:
Patients with history of suspected or proven angioedema or unable to tolerate ACEIs, ARBs or ARNI (e.g., due to cough, hypotension, renal dysfunction, hyperkalemia)
Use of sacubitril/valsartan in the past 3 months
Patients requiring continuous intravenous inotropic therapy or with indication of advanced support intervention for HF:
already on list for a heart transplantation
with current indication of left ventricular assist device, or cardiac resynchronization therapy (CRT)
Systemic systolic blood pressure lower than 95 mmHg or symptomatic hypotension
Serum potassium > 5.2 mmol/L
Estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m2 of body surface area
Severe gastrointestinal form of chronic Chagas' disease (demonstrated megaesophagus and/or important megacolon, e.g.: with compromised oral intake or surgical indication).
Clinical conditions or systemic diseases limiting proper patient participation
Pregnant or nursing women or women of child-bearing potential unless they are using highly effective methods of contraception
Presence of other cardiac conditions:
Previous cardiac surgery
Heart failure where, in the Investigator's judgement, there is a possible alternative primary etiology e.g., due to coronary artery disease, valve disease, congenital heart disease or other causes.
Untreated arrhythmia or serious conduction disease e.g., bradyarrhythmias, atrial fibrillation with rapid ventricular response, second or third degree atrioventricular block, etc.
Primary uncorrected valvar pathology like moderate to severe aortic stenosis, mitral stenosis and primary mitral regurgitation
Planned organ transplantation (or in listing for transplantation), planned cardiac or other major surgery (including ventricular assist device implantation)
History of malignancy of any organ system within the past 5 years.
Current confirmed COVID19 infection
Past COVID19 infection with persistent symptom burden suspected due to COVID19 (persistent symptoms may include, but are not limited to, continued cough, breathing difficulty, muscle/joint aches, and gastrointestinal symptoms from the time of COVID19 infection onward)
Study Location
Novartis Investigative Site
Recruiting
Cordoba,X5003DCE,Argentina
Novartis Investigative Site
Recruiting
San Miguel de Tucuman,Tucuman,T4000JCU,Argentina
Novartis Investigative Site
Recruiting
Mendoza,5500,Argentina
Novartis Investigative Site
Recruiting
Cordoba,X5004BAL,Argentina
Novartis Investigative Site
Recruiting
Santa Fe,S3000EOZ,Argentina
Novartis Investigative Site
Recruiting
Formosa,P3600,Argentina
Novartis Investigative Site
Recruiting
Mendoza,M5500CHC,Argentina
Novartis Investigative Site
Recruiting
Buenos Aires,C1155 AHD,Argentina
Novartis Investigative Site
Recruiting
Villa Maria,Cordoba,X5900JKA,Argentina
Novartis Investigative Site
Recruiting
Cordoba,X5004CDT,Argentina
Novartis Investigative Site
Recruiting
Santa Fe,S3000FWO,Argentina
Novartis Investigative Site
Recruiting
Ramos Mejia,Buenos Aires,B1704ETD,Argentina
Novartis Investigative Site
Recruiting
Temperley,Buenos Aires,1834,Argentina
Novartis Investigative Site
Recruiting
Formosa,P3600JUT,Argentina
Novartis Investigative Site
Recruiting
Buenos Aires,C1425AGP,Argentina
Novartis Investigative Site
Recruiting
Cordoba,X5006CBI,Argentina
Novartis Investigative Site
Recruiting
Formosa,P3634XAR,Argentina
Novartis Investigative Site
Recruiting
Buenos Aires,C1428DCO,Argentina
Novartis Investigative Site
Recruiting
Rosario,Santa Fe,2000,Argentina
Novartis Investigative Site
Recruiting
Cordoba,X5016KET,Argentina
Novartis Investigative Site
Recruiting
Santiago del Estero,G4200AQK,Argentina
Novartis Investigative Site
Recruiting
Tucuman,San Miguel De Tucuman,T4000ICL,Argentina
Novartis Investigative Site
Recruiting
San Martin,Buenos Aires,1604,Argentina
Novartis Investigative Site
Recruiting
Caba,Buenos Aires,C1221ADC,Argentina
Novartis Investigative Site
Recruiting
Corrientes,W3400,Argentina
Novartis Investigative Site
Recruiting
Rosario,Santa Fe,S2000DIF,Argentina
Novartis Investigative Site
Recruiting
Ciudad de Salta,Provincia De Salta,A4406BPF,Argentina
Novartis Investigative Site
Recruiting
San Miguel de Tucuman,Tucuman,T4000IFL,Argentina
Novartis Investigative Site
Recruiting
Caba,Buenos Aires,C1425BEI,Argentina
Novartis Investigative Site
Recruiting
Marilia,SP,17515-000,Brazil
Novartis Investigative Site
Recruiting
Sao Jose do Rio Preto,Sao Paulo,15015-210,Brazil
Novartis Investigative Site
Recruiting
Brasilia,DF,70390-903,Brazil
Novartis Investigative Site
Recruiting
Uberlândia,MG,38400-328,Brazil
Novartis Investigative Site
Recruiting
Ribeirao Preto,SP,14048-900,Brazil
Novartis Investigative Site
Recruiting
Goiania,GO,74223-130,Brazil
Novartis Investigative Site
Recruiting
Belo Horizonte,MG,30130-100,Brazil
Novartis Investigative Site
Recruiting
Sao Paulo,05403-000,Brazil
Novartis Investigative Site
Recruiting
Campinas,SP,13020-431,Brazil
Novartis Investigative Site
Recruiting
Salvador,BA,40110060,Brazil
Novartis Investigative Site
Recruiting
Sao Jose do Rio Preto,Sao Paulo,15015-750,Brazil
Novartis Investigative Site
Recruiting
Brasilia,Distrito Federal,70710-100,Brazil
Novartis Investigative Site
Recruiting
Rio de Janeiro,RJ,20551-030,Brazil
Novartis Investigative Site
Recruiting
Uberlandia,Minas Gerais,38411 186,Brazil
Novartis Investigative Site
Recruiting
Goiania,GO,74605-020,Brazil
Novartis Investigative Site
Recruiting
Passos,Minas Gerais,37904-020,Brazil
Novartis Investigative Site
Recruiting
Tatuí,SP,18270-170,Brazil
Novartis Investigative Site
Recruiting
Campinas,SP,13060 080,Brazil
Novartis Investigative Site
Recruiting
Salvador,BA,40323-010,Brazil
Novartis Investigative Site
Recruiting
Sao Jose do Rio Preto,SP,15090-000,Brazil
Novartis Investigative Site
Recruiting
Campinas,SP,13060-904,Brazil
Novartis Investigative Site
Recruiting
Salvador,BA,41253-190,Brazil
Novartis Investigative Site
Recruiting
Belem,PA,66087-660,Brazil
Novartis Investigative Site
Recruiting
Sao Luis,MA,65020-070,Brazil
Novartis Investigative Site
Recruiting
Rio de Janeiro,RJ,22240-006,Brazil
Novartis Investigative Site
Recruiting
Votuporanga,SP,15500 003,Brazil
Novartis Investigative Site
Recruiting
Botucatu,Sao Paulo,3880-1001,Brazil
Novartis Investigative Site
Recruiting
Ijui,98700-000,Brazil
Novartis Investigative Site
Recruiting
Recife,PE,50100-060,Brazil
Novartis Investigative Site
Recruiting
Teresina,Piaui,64001-380,Brazil
Novartis Investigative Site
Recruiting
Montes Claros,Minas Gerais,39401-001,Brazil
Novartis Investigative Site
Recruiting
Sao Paulo,01223-001,Brazil
Novartis Investigative Site
Recruiting
Braganca Paulista,Sao Paulo,13183-091,Brazil
Novartis Investigative Site
Recruiting
Indaiatuba,SP,13330-570,Brazil
Novartis Investigative Site
Recruiting
Recife,PE,52051-380,Brazil
Novartis Investigative Site
Recruiting
Belo Horizonte,MG,30140 062,Brazil
Novartis Investigative Site
Recruiting
Fortaleza,CE,60430 370,Brazil
Novartis Investigative Site
Recruiting
Natal,Rio Grande Do Norte,59020-035,Brazil
Novartis Investigative Site
Recruiting
Santo Andre,Sao Paulo,09080-001,Brazil
Novartis Investigative Site
Recruiting
Brasila,DF,70673623,Brazil
Novartis Investigative Site
Recruiting
Londrina,PR,86038-440,Brazil
Novartis Investigative Site
Recruiting
Uberaba,MG,38025-440,Brazil
Novartis Investigative Site
Recruiting
Ribeirao Preto,Sao Paulo,14010-190,Brazil
Novartis Investigative Site
Recruiting
Goiania,Goias,74223-060,Brazil
Novartis Investigative Site
Recruiting
Belo Horizonte,MG,30150-221,Brazil
Novartis Investigative Site
Recruiting
Sao Paulo,SP,04012 909,Brazil
Novartis Investigative Site
Recruiting
Salvador,BA,40050-410,Brazil
Novartis Investigative Site
Recruiting
Floridablanca,681004,Colombia
Novartis Investigative Site
Recruiting
Bogota DC,110111,Colombia
Novartis Investigative Site
Recruiting
Bogota,Cundinamarca,110121,Colombia
Novartis Investigative Site
Recruiting
Santa Marta,Magdalena,30360,Colombia
Novartis Investigative Site
Recruiting
San Gil,Santander,684031,Colombia
Novartis Investigative Site
Recruiting
Florida Blanca,681001,Colombia
Novartis Investigative Site
Recruiting
Pachuca,Hidalgo,42070,Mexico
Novartis Investigative Site
Recruiting
Guadalajara,Jalisco,44670,Mexico
Novartis Investigative Site
Recruiting
Merida,Yucatan,97000,Mexico
Novartis Investigative Site
Recruiting
Ciudad de Mexico,Cdmx,14080,Mexico
Novartis Investigative Site
Recruiting
Xalapa,91193,Mexico
Novartis Investigative Site
Recruiting
Ciudad de Mexico,Gustavo A Madero,07300,Mexico
Novartis Investigative Site
Recruiting
Oaxaca,68000,Mexico
Worldwide Contacts
If the location of your choosing does not feature any contact detail, please reach out using the information below.